391 related articles for article (PubMed ID: 21717140)
21. Synchronous primary ovarian and endometrial cancer with a fair prognosis in a young woman.
Yang YH; Chen RJ; Lin MC; Cheng SP; Chang TC
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):97-100. PubMed ID: 20466303
[No Abstract] [Full Text] [Related]
22. The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma.
Ju UC; Kang WD; Kim SM
Int J Gynaecol Obstet; 2019 Aug; 146(2):177-183. PubMed ID: 31081117
[TBL] [Abstract][Full Text] [Related]
23. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.
Silva EG; Young RH
Am J Surg Pathol; 2007 Aug; 31(8):1203-8. PubMed ID: 17667544
[TBL] [Abstract][Full Text] [Related]
24. Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.
Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Konishi I
Cancer Lett; 2011 Nov; 310(2):129-33. PubMed ID: 21802200
[TBL] [Abstract][Full Text] [Related]
25. Frequency of ovarian endometriosis in epithelial ovarian cancer patients.
Dzatic-Smiljkovic O; Vasiljevic M; Djukic M; Vugdelic R; Vugdelic J
Clin Exp Obstet Gynecol; 2011; 38(4):394-8. PubMed ID: 22268283
[TBL] [Abstract][Full Text] [Related]
26. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P
Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226
[TBL] [Abstract][Full Text] [Related]
27. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
[TBL] [Abstract][Full Text] [Related]
28. [Atypical endometriosis: a clinicopathologic study of 163 cases].
Guo DH; Pang SJ; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):831-4. PubMed ID: 19087566
[TBL] [Abstract][Full Text] [Related]
29. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study.
Chan JK; Tian C; Fleming GF; Monk BJ; Herzog TJ; Kapp DS; Bell J
Gynecol Oncol; 2010 Mar; 116(3):301-6. PubMed ID: 19945740
[TBL] [Abstract][Full Text] [Related]
30. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implication of endometriosis in clear cell carcinoma of the ovary.
Orezzoli JP; Russell AH; Oliva E; Del Carmen MG; Eichhorn J; Fuller AF
Gynecol Oncol; 2008 Sep; 110(3):336-44. PubMed ID: 18639330
[TBL] [Abstract][Full Text] [Related]
32. Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated?
Vercellini P; Viganò P; Buggio L; Makieva S; Scarfone G; Cribiù FM; Parazzini F; Somigliana E
Best Pract Res Clin Obstet Gynaecol; 2018 Aug; 51():151-168. PubMed ID: 29551389
[TBL] [Abstract][Full Text] [Related]
33. New insights in the pathophysiology of ovarian cancer and implications for screening and prevention.
Nezhat FR; Apostol R; Nezhat C; Pejovic T
Am J Obstet Gynecol; 2015 Sep; 213(3):262-7. PubMed ID: 25818671
[TBL] [Abstract][Full Text] [Related]
34. When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes.
Duska LR; Garrett L; Henretta M; Ferriss JS; Lee L; Horowitz N
Gynecol Oncol; 2010 Mar; 116(3):374-7. PubMed ID: 19922988
[TBL] [Abstract][Full Text] [Related]
35. Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?
Sahin H; Sari ME; Cuylan ZF; Haberal AN; Sirvan L; Coban G; Yalcin I; Güngör T; Celik H; Meydanli MM; Ayhan A
Arch Gynecol Obstet; 2018 Apr; 297(4):1005-1013. PubMed ID: 29383437
[TBL] [Abstract][Full Text] [Related]
36. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
Erzen M; Rakar S; Klancnik B; Syrjänen K
Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420
[TBL] [Abstract][Full Text] [Related]
37. Endometrioid adenocarcinoma of the ovary arising from endometriosis and presenting as an acute abdomen.
Maruthini D; Amin A; Buxton J
J Obstet Gynaecol; 2007 Jul; 27(5):540-1. PubMed ID: 17701820
[No Abstract] [Full Text] [Related]
38. The role of p53 mutation in the carcinomas arising from endometriosis.
Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T
Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of prognostic factors of epithelial ovarian carcinoma].
Shao SL; Liu XS
Zhonghua Fu Chan Ke Za Zhi; 2010 Feb; 45(2):132-6. PubMed ID: 20420785
[TBL] [Abstract][Full Text] [Related]
40. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis.
McMeekin DS; Burger RA; Manetta A; DiSaia P; Berman ML
Gynecol Oncol; 1995 Oct; 59(1):81-6. PubMed ID: 7557621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
